CTGF can increase collagen in the human body [24–26] and has been investigated for its role in various fibrotic and desmoplastic diseases, including fibrotic skin disorder, organ fibrosis, and HCC [27–29]. This evidence concerns the gene CCN2 and hepatocellular carcinoma.